Monday, September 07, 2020 11:39:31 AM
I believe that Relief therapeutics will do a RS. Humanigen did a RS at 1:5 last week. Humanigen share price is over $2 per share now. Relief therapeutics OS is too high. The company is preparing for the Nasdaq. In order to have the share price in dollar land, they will do a RS. Investors will lose shares but the share value will increase in the end. I've been through 2 RS with another penny stock. I survived because I bought a lot of shares before the RS. You can also wait & buy after the RS at a higher price.
Humanigen has developed a monoclonal antibody that targets the cytokine storm with the Corona virus. It has the same effect/results as aviptadil. But I feel that the antibody drug, lenzilumab, will cost more to manufacture.
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM